Ord5tZ4Q8JI https://histock.tw/talk/live.aspx?name=gtalk&id=1325 20250423 阿布波

台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    42.05
  • 漲跌
    ▲0.95
  • 漲幅
    +2.31%
  • 成交量
    35
  • 產業
    上市 生技醫療類股▲2.07%
  • 127人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-元大-蘆洲中正 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/3004/1204/2205/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2403/0603/1804/2430354045505560May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元大-蘆洲中正 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/21141.6500.0041.6012700.37%
2025/04/14139.3500.0039.7013140.32%
2025/04/08139.0000.0039.5013270.31%
2025/03/31043.6100.0043.0003220.00%
2025/03/2700.00145.9045.90-1319-0.31%
2025/03/24045.1000.0044.9003210.00%
2025/03/19045.5500.0045.3003260.00%
2025/03/18045.8500.0045.8503300.00%
2025/03/11249.4300.0049.5023360.59%
2025/03/10050.2000.0050.4003350.00%
2025/03/07249.9000.0050.2023340.60%
2025/03/06149.7500.0050.9013310.30%
2025/03/0300.001053.3553.00-10297-3.36%
2025/02/271052.60154.0052.7092863.15%
2025/02/2400.00150.4050.10-1276-0.36%
2025/01/1700.00149.8049.80-1228-0.44%
2025/01/1500.000.250.4049.30-0.2222-0.09%
2025/01/1300.000.152.4052.00-0.1208-0.02%
2025/01/1000.000.153.0851.70-0.1198-0.03%
2025/01/0800.00152.3051.70-1184-0.54%
2025/01/07152.60452.5052.10-3176-1.70%
2025/01/060.251.10151.2050.80-0.8159-0.50%
2025/01/03150.100.349.8650.100.71460.48%
2025/01/0200.000.149.4549.00-0.1137-0.06%
2024/12/1100.001.548.4248.65-1.5121-1.24%
2024/11/200.142.3000.0042.400.11060.09%
2024/11/08143.55143.8043.8001200.00%
2024/10/0400.00141.9541.95-1255-0.39%
2024/10/010.142.2500.0042.550.12610.04%
2024/09/0500.00145.0045.25-1409-0.24%
2024/08/2900.00146.7046.55-1432-0.23%
2024/08/070.140.8000.0040.850.14180.02%
2024/08/022.143.3600.0042.302.14060.52%
2024/07/2900.00143.0543.00-1401-0.25%
2024/07/26144.3000.0044.3013960.25%
2024/07/220.146.7000.0046.500.13910.03%
2024/07/190.147.0000.0046.500.13840.03%
2024/07/18247.8800.0048.0023460.58%
2024/07/02351.30350.0750.4002620.00%
2024/07/01449.15449.8050.2002140.00%
2024/06/2600.00546.7046.85-5179-2.78%
2024/06/2400.00045.9546.0501710.00%
2024/06/2000.00145.7045.95-1168-0.59%
2024/06/1800.000.146.4046.35-0.1165-0.06%
2024/06/07145.25145.6045.6001550.00%
2024/06/05145.30145.0044.9001530.00%
2024/06/0400.00144.8544.30-1149-0.67%
2024/05/310.143.1000.0042.250.11400.07%
2024/05/30142.5000.0042.2011400.71%
2024/05/2100.00143.4043.40-1136-0.73%
2024/05/1700.000.143.3543.60-0.1135-0.04%
2024/05/1300.00143.6043.55-1142-0.70%
2024/05/10043.1500.0043.4001550.00%
2024/05/08142.2500.0042.7011540.65%
2024/05/0600.00142.7042.80-1153-0.65%
2024/05/02042.95543.0043.00-5154-3.23%
2024/04/2600.00142.2542.25-1155-0.64%
2024/04/25042.6500.0042.5001550.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章